protocol ExtEnsion naturE protocols | VOL.13 NO.5 | 2018 | 819 introDuction DNA replication occurs during the S phase of the cell cycle. In human cells, this process typically lasts for 8-10 h 1 . Different regions of the genome replicate at different times during S phase, following a defined RT program [2] [3] [4] [5] [6] [7] [8] . The reader is referred to many recent reviews of RT in mammalian cells and its association with mutation rates 9 , chromatin and transcription [10] [11] [12] [13] [14] [15] .
RT patterns, or the effects of genetic manipulations. RT is highly cell-type specific, with 50% of the genome changing RT across many mammalian cell types [2] [3] [4] [5] [6] 8 . We previously developed computational methods to detect RT fingerprints, which rank regions of differential RT between two supervised groups of samples by their statistical significance 7 , and to identify RT signatures of genomic segments that replicate uniquely to specific groups of samples by unsupervised clustering analysis 8 . The latter is a powerful method for assessing the identity of cells or for stratifying diseased versus healthy patient samples by their RTs (ref. 8 and data not shown, J.C.R.-M. and D.M.G.), e.g., in certain subtypes of pediatric acute lymphoblastic leukemia 20, 28 . In cases in which the haplotypes within a sample are phased, Repli-seq can provide allele-specific information. An allele specificity for RT has been demonstrated in human 22 (see Alternative methods) and in mouse hybrid cells 29 .
Alternative methods
Multiple techniques have been developed to assess RT in mammalian cells 4, 16, 17, 30 . Alternative variations of Repli-chip and Repli-seq include performing the same basic BrdU labeling and enrichment method, but sorting multiple fractions of S phase 4, 16, 17 , . E/L and multifraction Repli-chip or Repli-seq produce highly similar profiles after smoothing and normalization, and, as large segments of DNA are rapidly labeled with BrdU, multiple fractions can increase resolution only marginally 25 . Multiple fractions can, however, provide information on the synchrony of replication across a population of cells during S phase. Highly asynchronous replication would be revealed by multiplefraction analysis as BrdU incorporation across S phase, but would be indistinguishable from middle S-phase replication if the E/L method is used. Nevertheless, asynchronous replication is very rare, so when the main goal is to generate a genome-wide profile of a given cell type or experimental condition, particularly when comparing many samples, the E/L protocol is preferred because it is considerably faster in both experimental and computational processing, provides highly reliable data with well-established quality control standards and can be easily integrated into nextgeneration sequencing analysis pipelines. Importantly, the use of a binary ratio of enrichment provides an internal control for sequence mappability, eliminating most concerns over sequence biases or copy-number variation relative to the reference genome. These concerns over biases must be taken into account when assessing RT by multifraction Repli-seq, which processes each fraction separately.
Repli-seq requires cells to be metabolically labeled with a nucleotide precursor such as BrdU. Metabolic labeling of nascent DNA offers an enormous enrichment for the sequences replicated within a defined time, giving a robust dynamic range to the data. However, although measurements of DNA replication must be performed with cells in S phase, occasionally, samples do not lend themselves to metabolic labeling, e.g., if they are frozen banked samples of proliferating cells that are no longer viable 20 . In this case, one can isolate populations of cells throughout S phase, and compare DNA copy numbers of sequences throughout the genome to the DNA copy numbers of the same cell population sorted on G1-phase DNA content. The ratio of DNA in S versus G1 (S/G1) is proportional to the time during S phase that a DNA segment replicated, because sequences that replicate early are at a higher overall copy number in the total S-phase population relative to sequences that replicate later. This method can be applied using either microarray or sequencing, but the maximum dynamic range is less than two fold, so the data are inherently more noisy, although the binary ratio again controls for mappability biases and copy-number variation relative to the reference genome 20, 22, 31 . Another method that has been applied and avoids metabolic labeling is measurement of the copy numbers of sequences derived from wholegenome sequencing of samples with no cell cycle enrichment (i.e., asynchronous samples), such as the data sets provided by the 1000 Genomes Project 32 . This method has the advantage of leveraging existing whole-genome sequencing databases. However, in order to obtain an interpretable RT profile, substantial sequencing depth is needed, and the dynamic range is very low and dependent upon the percentage of cells that were in S phase. Also, this method cannot distinguish actual RT change from differences in copy number and structural variation between samples.
Limitations E/L Repli-seq is a powerful method for studying RT, but, as with all methods, it presents some limitations. First, compared with Repli-chip, Repli-seq is more expensive, and the data are more difficult to computationally process. Second, although the bimodal ratio of DNA enrichment in two S-phase fractions provides an internal correction for sequencing, mappability and copy-number biases, it cannot detect replication that takes place over a broader time period (kinetic differences) or replication pause sites that are masked by smoothing. Detection of these properties of replication requires multiple-fraction Repli-seq. In some cases, a higher time resolution may be desired, but the current multifraction Repli-seq data production/analysis has not increased time resolution as compared with the E/L method 6, 25 . Third, because we use BrdU labeling, only cells expressing a thymidine kinase can be used. Some examples of thymidine kinase-deficient cell lines are mouse L-M(TK-) (LM(tk-), LMTK-) (ATCC, cat. no. CCL-1.3), rat Rat2 (ATCC, cat. no. CRL-1764); these cannot be analyzed with Repli-seq. Fourth, as with all ensemble methods, E/L Repliseq represents the average RT of a cell population. Finally, cellto-cell variability cannot be measured with this technique; singlecell Repli-seq is necessary to assess stochastic variability of RT within a cell population 33 .
Experimental design
The experimental part of this protocol begins with cultured cells and ends with sequencing of the samples; it is composed of nine stages, each of which is described in more detail in the following sections. This is followed by the analysis part of the protocol, which starts from the .fastq or .fastq.gz files obtained after sequencing, and generates normalized bedGraph files that can be used for further bioinformatics studies. An overview of the protocol is presented in Figure 1 .
Labeling and fixation (Steps 1-10).
This stage is performed on cells that can be pulse-labeled; these include any cell type that is proliferating and expresses a thymidine kinase, and that can be dissociated into single cells. Some clinical specimens can be problematic if their preservation has impaired their viability and they can no longer incorporate nucleosides. For these types of samples, we recommend either avoiding the BrdU labeling by using the S/G1 method or performing rejuvenation in immunodeficient mice as described in Sasaki et al. 20 . Finally, some tissue samples may be difficult to dissociate, and alternative methods of dissociation can be tried, as described 34 . Asynchronously proliferating cells are pulse-labeled with BrdU to mark newly synthesized DNA. The resolution of Repli-seq is currently limited by the percentage of the genome that must be labeled for efficient BrdU IP, which is ~10% of the genome (1-h minimum labeling time). Shorter labeling times result in a high proportion of unlabeled DNA contamination, increasing noise. As eukaryotic cells replicate their genomes as spatially clustered replicons, generally large domains are labeled in a short period of time 35 . The optimal concentration of nucleoside may also be affected by the cell type (e.g., endogenous nucleoside pools) or culture media. If desired, BrdU can be replaced by EdU, and the pull-down can be performed by click chemistry, but we are still optimizing the conditions for EdU labeling and determining the degree of improved resolution; BrdU IP is less expensive and faster than EdU click chemistry.
FACS sorting (Steps 11-18).
BrdU-labeled cells are stained with propidium iodide (PI) to assess the cell cycle phase of each cell. Cells are sorted by FACS according to their DNA content (determined on the basis of the PI staining) to isolate two cell populations: early-S cells and late-S cells ( Supplementary  Fig. 1 ). Many other DNA-staining dyes may use, e.g., chromomycin, mithramycin, DAPI, Hoechst or DRAQ5, in place of PI, depending on the fluorescence wavelengths and applications desired 34 . We sort 20,000 cells per fraction, although we have generated good-quality data with as little as 1,000 cells (we do not recommend this for first-time users).
DNA preparation (Steps 19-24).
Early and late sorted S-phase cells are lysed by SDS/proteinase K digestion, and genomic DNA is isolated using Zymo Quick-DNA purification. Theoretically, any genomic DNA preparation should work, but Zymo's kit is designed for small amounts of DNA in small volumes. It is also fast, as it does not involve pelleting and dissolving DNA.
Fragmentation (Steps 25-28).
Purified DNA is fragmented by sonication using a Covaris ultrasonicator. The advantages of the Covaris instrument are as follows: (i) it reproducibly fragments DNA into a relatively tight size distribution, and hence there is usually no need for subsequent size selection; (ii) the same conditions work for a broad range of DNA concentrations (50-5,000 ng per sonication). Although Covaris consumables are expensive, these advantages make the total cost of library construction lower than fragmentation of DNA using other methods. The fragmentation is performed to obtain DNA fragments of an average length of 200 bp if 50-to 100-bp single-end sequencing is to be performed. Fragment size can be adapted for specific purposes; e.g., for experiments in which we wish to detect SNPs in phased genomes, we fragment to > 500-bp fragments and perform 250-bp pairedend sequencing.
Library construction (Steps 29-36)
. DNA libraries are constructed before the BrdU-labeled DNA IP (BrdU IP), which has multiple advantages. First, the amount of available DNA is higher than that after the IP, and constructing libraries from small amounts of DNA is challenging. Second, BrdU IP yields single-stranded DNA, which means that constructing the libraries after the BrdU IP would require converting it back to doublestranded DNA, which adds one more step to the protocol and could introduce artifacts. Importantly, our method also allows one to quantify the efficiency of the BrdU IP by quantitative PCR of immunoprecipitated versus input DNA (see Step 54 and the Supplementary Methods, 'BrdU IP efficiency measurement' section). The kit used to construct the library depends on the sequencer you will use. We use an NEB kit for Illumina sequencing, which presents a couple of advantages: (i) NEB adaptors are designed to minimize adaptor dimer formation, which is a 
Analysis (Steps 79-94).
Reads are mapped onto the genome using bowtie2. The coverage is assessed for each sample, and the base 2 log ratio of early versus late S-phase samples is calculated in genomic windows of 5 or 50 kb. All analysis steps are performed using R software or in the command line. Next, base 2 log ratio files are post-processed using R. Post-processing allows comparison between samples when comparing samples with local RT changes. Post-processing includes quantile normalization and Loess smoothing. We do not recommend using quantile normalization when comparing data sets with expected global RT changes, as it could mask the effect of global RT misregulation in samples with a massive shift in S-phase read distribution, e.g., in a Rif1 knockout 36 . Loess smoothing helps to reduce noise. The analysis generates one bedGraph coverage file of the post-processed log2 ratio of early versus late S-phase cells per sample. These files can be viewed using a genome viewer (IGV 37 • 46 (http://www.htslib.org/download/) bedtools 47 (http://bedtools.readthedocs.io/en/latest/index.html) (Optional) harp (http://github.com/dvera/harp) REAGENT SETUP Cells of interest Cultures can be grown in any size cell culture dish, but they must be in an actively dividing state for use in this protocol. If you must start from frozen samples that were proliferating at the time they were frozen but are no longer metabolically active, use the S/G1 method described by Ryba et al. 18 . As FACS can be problematic with a low cell number, we recommend starting with > 2 × 10 6 cells. We have successfully profiled RT using as few as 300,000 starting cells, and as few as 1,000 early and late S-phase cells after sorting, but cells are lost during PI staining, filtering and sorting, so we do not recommend trying this without extensive experience. ! caution All experiments should be performed in accordance with relevant health, safety and human subjects guidelines and regulations. BrdU Make stock solutions of 10 mg/ml (and 1 mg/ml if you need to handle a small scale of culture) in ddH 2 O (warm up in a 37 °C water bath to dissolve completely) and store at − 20 °C in 1-ml aliquots, protected from light. Aliquots can be stored for > 2 years. Repeated freeze/thaw is fine. PI (1 mg/ml) To make a 20-ml solution, dissolve 20 mg of PI powder in autoclaved ddH 2 O to achieve a final volume of 20 ml; then filter the solution. Store for up to 1 year at 4 °C protected from light. 1-ml aliquots are convenient. 
PBS/1% (vol/vol) FBS/PI/RNase

SDS-PK buffer
To make 50 ml of SDS-PK buffer, combine 34 ml of autoclaved ddH 2 O, 2.5 ml of 1 M Tris-HCl, pH 8.0, 1 ml of 0.5 M EDTA, 10 ml of 5 M NaCl and 2.5 ml of 10% (wt/vol) SDS in H 2 O. Store at room temperature indefinitely. Warm to 56 °C before use to completely dissolve the SDS. 10× IP buffer To make 50 ml of IP buffer, combine 28.5 ml of ddH 2 O, 5 ml of 1 M sodium phosphate, pH 7.0, 14 ml of 5 M NaCl and 2.5 ml of 10% (wt/vol) Triton X-100 in H 2 O. Store at room temperature indefinitely. Anti-BrdU antibody, 12.5 µg/ml Dilute the stock concentration of 0.5 mg/ml antibody in 1× PBS to a final concentration of 12.5 µg/ml. Prepare 40 µl of diluted antibody for each sample. Diluted antibody should be used on the same day and should not be saved. Digestion buffer To make 50 ml of digestion buffer, combine 44 ml of autoclaved ddH 2 O, 2.5 ml of 1 M Tris-HCl, pH 8.0, 1 ml of 0.5 M EDTA and 2.5 ml of 10% (wt/vol) SDS in H 2 O. Store at room temperature, indefinitely. NEBNext Ultra DNA Library Prep Kit for Illumina (E7370) The ligation master mix and ligation enhancer can be mixed ahead of time, and the mixture is stable for at least 8 h at 4 °C. We do not recommend premixing the ligation master mix, ligation enhancer and adaptor before use in the adaptor ligation step. 1| Add BrdU to medium to a final concentration of 100 µM.
2|
Incubate for 2 h at 37 °C in a tissue culture incubator for BrdU incorporation.
3|
Gently rinse the cells twice with 5 ml of ice-cold PBS.
4| Trypsinize the cells with 2 ml of 0.2× Trypsin-EDTA for 2-3 min (incubation temperature varies depending on the cell line used; please refer to the provider. Here, F121-9 cells are trypsinized at room temperature).
5| Add 5 ml of complete medium, pipette gently but thoroughly, and transfer to a 15-ml round-bottom tube.  critical stEp Using round-bottom tubes for cell fixation prevents cells from forming a packed pellet that is hard to resuspend later, but if a small cell number is an issue, use of conical tubes is fine.
6|
Centrifuge the cells at 200g for 5 min at room temperature.
7| Decant (or aspirate) the supernatant carefully. 8| Add 2.5 ml of ice-cold PBS/1% (vol/vol) FBS, and pipette gently but thoroughly.  critical stEp Using a hemocytometer or any cell counter, double-check the cell number at this point. After adding ethanol, it will be harder to count cells, as FBS deposits as a sediment upon addition of ethanol. 9| Add 7.5 ml of ice-cold 100% (vol/vol) EtOH, dropwise while gently vortexing.  critical stEp Use the lowest speed or shake the tube by hand to avoid cell lysis caused by vigorous vortexing.
10|
Seal the cap and mix the tube gently, but thoroughly, by inverting several times; store at − 20 °C until use.  pausE point Fixed cells are stable at − 20 °C for more than a year if protected from light (BrdU is light sensitive) and evaporation. Lower temperature may cause freezing, which damages cells.
Facs sample preparation and sorting • tiMinG 1.5 h  critical The following steps describe the procedure for sorting whole, single cells. If the condition of the fixed cells is poor, e.g., if there are many cell aggregates in the suspension, or if the cell sorter does not allow sorting of whole cells, e.g., because its nozzle is too narrow, the 'nuclei preparation' procedure (supplementary Methods) can be used. 11| Transfer 2 × 10 6 cells from Step 10 to a new 15-ml conical tube.
12|
Centrifuge at ~200g for 5 min at room temperature and decant the supernatant carefully.
13|
Resuspend the cell pellet in 2 ml of 1% (vol/vol) FBS in PBS. Mix well by tapping the tube.
14| Repeat Step 12.
15| Resuspend the cell pellet in 0.5 ml of PBS/1% (vol/vol) FBS/PI/RNase A, aiming to reach a final concentration of 3 × 10 6 cells per ml.
16|
Tap the tube to mix and then incubate for 20-30 min at room temperature in the dark (count the cells during this time and adjust the cell concentration to 3 × 10 6 cells per ml either by adding more PBS/1% (vol/vol) FBS/PI/RNase A or by centrifuging, removing the supernatant and resuspending the pellet in an appropriate volume, if necessary).
17|
Filter the cells by pipetting them through a 37-µm nylon mesh into a 5-ml polypropylene round-bottom tube. Keep the samples on ice in the dark and proceed directly to FACS sorting.  pausE point Alternatively, add 1/9 vol. DMSO and freeze at − 80 °C (light protected) until sorting. Frozen cells can be stored indefinitely. Upon sorting, thaw the cell suspension in a 37 °C water bath and keep the samples on ice in the dark. Removing the DMSO is not necessary.
18|
Collect 120,000 early and 120,000 late S-phase cells by FACS sorting (a total of 120,000 cells allows six reactions with BrdU IP). 21| Add 1 ml of SDS-PK buffer containing 0.2 mg/ml proteinase K to every 100,000 cells collected (although we aim to collect 120,000 cells per fraction, 'early S' and 'late S' fractions do not always have the same number of cells. The cell sorter keeps collecting cells until both the 'early S' and the 'late S' fractions have at least 120,000 cells. Alternatively, one may obtain < 120,000 cells due to a low S-phase population. In such cases, add 1 ml of buffer to every 100,000 cells to adjust the cell concentration) and mix vigorously by tapping the tube. Seal the tube cap with Parafilm to prevent them from popping off during Step 22.
22|
Incubate the samples in a 56 °C water bath for 2 h. library construction • tiMinG 3 h  critical After each step, purified DNA can be stored at − 20 °C indefinitely. Pausing after enzyme reaction without DNA purification is not recommended. We perform all the enzyme reactions in 0.5-ml PCR tubes, using a thermal cycler equipped with heat blocks for 0.5-ml tubes for convenience (0.5-ml tubes can hold these relatively large volumes of reactions, and DNA purification can be done afterward in the same tube). If you do not have access to a thermal cycler equipped with heat blocks for 0.5-ml tubes, reactions can be divided into multiple smaller PCR tubes. 29| Prepare the following mixture in a 0.5-ml PCR tube, using your fragmented DNA and the NEBNext Ultra DNA Library Prep Kit: 40| Denature the DNA from Step 37 at 95 °C for 5 min and then cool on ice for 2 min. Briefly spin (5 s at maximum speed at room temperature) to collect any condensation on the tube cap to the bottom of the tube.
41| Add the denatured DNA from
Step 40 to the prepared tubes with 10× IP buffer from Step 38.
42| Add 40 µl of 12.5 µg/ml anti-BrdU antibody to each tube.
43|
Incubate for 20 min at room temperature with constant rocking.
44| Add 20 µg of rabbit anti-mouse IgG.  critical stEp Anti-mouse IgG concentration differs by lot. Check certificate of analysis for concentration details. Concentration is usually from 2 to 4.5 mg/ml.
45|
46|
Centrifuge at 16,000g for 5 min at 4 °C and remove the supernatant.
47|
Briefly spin (5 s at maximum speed at room temperature) the samples and remove the remaining supernatant, first using 200-µl tips, followed by 10-µl tips.  critical stEp Make every effort to completely remove the supernatant.
48| Add 750 µl of the chilled 1× IP buffer from
Step 39.
49| Repeat Steps 46 and 47.
50| Resuspend the pellet in 200 µl of digestion buffer with freshly added 0.25 mg/ml proteinase K and incubate the samples overnight at 37 °C in an air incubator.  critical stEp If you do this in a water bath, water in the reaction evaporates and creates condensation under the cap during the overnight incubation, leaving almost no solution at the bottom of the tube.
51| Add 1.25 µl of 20 mg/ml proteinase K to each tube.
52| Incubate the samples for 60 min at 56 °C (water bath or heat block).
53| Purify the DNA using DNA Clean & Concentrator-5, following the manufacturer's instructions. Elute the purified DNA in 16 µl of H 2 O.  pausE point The purified DNA can be stored indefinitely at − 20 °C protected from light.
indexing and amplification • tiMinG 1.5 h 54| (Optional) To estimate the DNA yield of your BrdU-IP and determine the optimal PCR cycle number for indexing, perform a qPCR using primers that anneal to the adaptors (in this case, NEBadqPCR_F: ACACTCTTTCCCTACACGACGC and NEBadqPCR_R: GACTGGAGTTCAGACGTGTGC) and perform serial dilution of a previous NGS library with a known concentration as standard (supplementary Methods, 'BrdU IP efficiency measurement' section).
55|
Mix the following components in 0. 48 for more information about gel electrophoresis). A smear of ~350 bp is expected. If no smear is detected, you must re-amplify the reaction (the procedure for re-amplification is described in Box 1).  critical stEp The PCR program is basically the same as for indexing (Step 56), but the cycle number is adjusted depending on the original template concentration. Our equipment and this primer set amplify DNA ~1.7 times per cycle (this could vary depending on the thermal cycler). In addition, 60-70% of PCR product will be lost during post-PCR purification. Altogether, use ten cycles for 100-fold amplification, six to seven cycles for tenfold amplification or four to five cycles for threefold amplification.  critical stEp Avoid overamplification, to prevent library dimer, trimer and so on formation. 3. Purify the PCR product and quantify the DNA using Qubit as in Steps 58-71. 61| Add 90 µl of resuspended AMPure XP beads to the 100-µl PCR reaction. Mix well by pipetting up and down at least ten times.  critical stEp If you start from poorly fragmented DNA and you are sure you need to perform size selection at this time, refer to NEB manual E7370 and optimize the volume of AMPure XP beads to use. Briefly, save the supernatant from the first selection to remove larger fragments that bind to the beads, then add more AMPure XP beads to bind the fragments of target size and discard the supernatant this time, wash the beads with 80% (vol/vol) ethanol as in Steps 64-67 and elute the target-size fragments from the beads as in Step 68.
62|
Incubate for 5 min at room temperature.
63|
Freshly prepare 600 µl of 80% (vol/vol) ethanol per sample by diluting 100% (vol/vol) ethanol with H 2 O.
64|
Briefly spin (5 s at maximum speed at room temperature) the tubes from
Step 62 in a microcentrifuge and place the tubes on a magnetic stand to separate the beads from the supernatant. Once the solution is clear (~5 min), carefully remove and discard the supernatant.
65| Add 200 µl of 80% (vol/vol) freshly prepared ethanol from
Step 63 to each tube while in the magnetic stand. Incubate at room temperature for 30 s, and then carefully remove and discard the supernatant.
66|
Repeat Steps 64 and 65 two more times for a total of three washes. 
67|
Quality control and pooling • tiMinG 5 h 71|
Check the DNA concentration using 1 µl of the library from
Step 70 with a Qubit dsDNA HS Assay Kit, following the manufacturer's instructions. A DNA yield of 10-20 ng/µl is expected. If the concentration is below the detection limit, perform another Qubit assay using 10 µl of DNA library. This helps to determine the number of PCR cycles necessary for re-amplification.  critical stEp If the DNA concentration is < 7 ng/µl, you will have problems making the final 10 nM pool, so you will need to re-amplify the sample. Please note that it is better to use more PCR cycles at Step 56 rather than re-amplifying, because re-amplification increases the risk of bias by PCR, as well as includes one more purification step, which costs more, is time-consuming and could be another source of bias. Re-amplification can be done by following the procedure described in Box 1.
? trouBlEsHootinG 72| If your sample is from a mouse or human and you are using 2 ng/µl dilutions of each library as templates, check the early and late fraction enrichment by following the procedure described in Box 2, using the primer sets listed by Ryba et al. 18 . See Step 74, estimate the molar concentration of each library using the Bioanalyzer's region function).  critical stEp: The number of libraries to pool is important to reaching a good sequencing depth. For human or mouse samples, 5 million mapped reads per library gives usable data, which correspond to ~10 million sequenced reads (depending on the quality of the sequencing). Our HiSeq2500 generates ~160 million reads per lane, so we usually pool 12-16 libraries per lane. Pooling fewer than four indexes is not recommended because of the low complexity of the index.
76|
Mix equal volumes of each 10 nM library to make a pool. One pool fills one sequencing lane.  critical stEp Consult your sequencer operator regarding minimal sample concentration and volume.  pausE point The DNA library pool can be stored at − 20 °C indefinitely.
77|
Quality control of the pool(s). Take 1 µl from each pool and quantify it on a Qubit fluorometer as in Step 71. Adjust the concentration to 0.5 ng/µl. Run 1 µl of each pool on a Bioanalyzer DNA high-sensitivity chip to determine the average fragment size of the pool, which should be ~350 bp.  critical stEp As the target size is small enough, this two-step PCR works without an extension step. However, it is important to adhere to these annealing conditions (45 s is relatively long), so that the primer can start extension slowly during the annealing instead of suddenly being stripped from the template by heating for the next cycle of denaturation.
Box 2 | Early over late fraction enrichment validation in human and mouse
3. Run 4-5 µl of each PCR product (addition of loading buffer is not necessary for One Taq PCR) on a 1.5% (wt/vol) agarose gel containing 0.1 µ/g/ml EtBr to separate 150-to 450-bp fragments in your gel system to check the size of PCR products (specificity of PCR) and target enrichment. Each PCR product is from either 'a typical early replicating locus' or 'a typical late replicating locus,' and hence, it should be enriched in either the 'early S' library or the 'late S' library. 78| Sequence the pooled libraries on a Hi-seq Illumina sequencer. Generally, 50-bp single-end reads are sufficient for normal samples covering the unique sequences of the genome. However, longer reads may facilitate allele-specific alignment.
Data analysis • tiMinG 1 d
 critical Data analysis is performed on .fastq or .fastq.gz files, and outputs genomic coverage files with the log ratio of early versus late S-phase samples. This pipeline is written to process files with names that follow a specific nomenclature: early-and late-sequencing data originating from the same sample must have matching names, with an '_E_' before the extension of the file from early S cells, and an '_L_' before the extension of the file from late S cells. If you use paired-end sequencing data, paired files must be named with 'R1' and 'R2', respectively, before the extension. Examples of single-end .fastq file names could be 'my_sample_1_E_.fastq' and 'my_sample_1_L_.fastq' . Paired-end .fastq file names could be 'my_sample_1_E_R1.fastq' for read 1 and 'my_sample_1_E_R2.fastq' for read 2 of the same fraction. You can also directly use a similar pipeline available on https://www.github.com/dvera/shart.
79| Control the quality of the reads using .fastqc according to the instructions provided at http://www.bioinformatics.babraham.ac.uk/projects/fastqc. ? trouBlEsHootinG 80| Open a shell, go to the .fastq files directory and generate the Windows file by running the commands below. Replace 'path/to/files' in bold with the path to the .fastq files directory, and replace 'your genome.chrom.sizes' in bold with the chrom.sizes file name (and path, if the file is not in your working directory). You can also change the window size and step by replacing the bold '50000' with the desired sizes in kilobytes. Depending on the further analysis performed on the RT data sets, we use genomic windows from 5 to 50 kb.
$ cd path/to/files/ $ sort -k1,1 -k2,2n your_genome.chrom.sizes > your_genome_sorted.chrom.sizes $ bedtools makewindows -w 50000 -s 50000 -g your_genome_sorted.chrom.sizes > your_genome_windows.bed  critical stEp This step requires the chrom.sizes file of the genome you will use for the analysis. Many of these files can be directly downloaded from the UCSC server at ftp://hgdownload.cse.ucsc.edu/goldenPath/. This file contains two columns: one with the chromosome name and one with its size in bp, separated by a tabulation. This file must be sorted on the first column, following alphabetic order (e.g., 'chr10' will be before 'chr2'). 84| Set the data sets to use for quantile normalization by using the following commands (bold names must be adapted). To normalize on the basis of all imported data sets, follow option A; to normalize on the basis of one data set, follow option B or follow option C to normalize on a specific list of data sets: 88| Check the list of selected chromosomes, by running the following command:
81|
> chrs
89|
Initialize an R-list to stock your data sets, by running the following command:
90|
Perform Loess smoothing by running the following commands (this smoothing is similar to the Loess smoothing used by Ryba et al. 18 for Repli-chip analysis). The size used for span value (in bold) can be adapted. A span of 300 kb per length of the chromosome gives an appropriate span that can be increased for noisy data sets. $ cd path/to/files/ $ bedtools unionbedg -filler "NA" -i *Loess.bedGraph > merge_Loess_norm_RT.txt 93| (Optional) Your RT data are now registered into the bedGraph files in your repertory. Visualize them using a genome viewer (IGV, IGB or the UCSC Genome Browser) or on our replication domain platform (http://www.replicationdomain.org).
94| (Optional) Perform quality controls (correlation between replicates, autocorrelation function (ACF)) and further analysis (segmentation, switching domains identification and characterization) as described in
Step 83 of our previous Repli-chip procedure 18 .
? trouBlEsHootinG Troubleshooting advice can be found in RT modifications 28 . Moreover, assessing how a condition (e.g., drug treatment of cells or genetic knockout) affects RT can be challenging because changes can be subtle or localized 49, 50 . The method we present here is highly reproducible, yielding high correlations between technical replicates (repeats of library preparation from the same batch of BrdU-labeled cells), biological replicates (repeats of the entire PROCEDURE with a different batch of culture) and polymorphic biological replicates (same cell type from different individuals), allowing detection of small differences between samples. In fact, when the quality control standards are met (Steps 71-73, 77, 79 and 94), a single run of our method produces enough data to compare many different experimental conditions with high confidence. Although Repli-seq is reproducible when simply plotting the raw log 2 E/L ratios, our successive steps of normalization (Steps 84 and 85 and 87-92) lead to even higher correlation between replicates (Fig. 2) , which makes comparisons of closely related specimens quite facile, allowing high-confidence identification of small differences between different samples. Additional statistical methods, developed to compare RT data sets with very few localized differences, can be found in refs. 7 and 50.
accuracy Repli-chip has successfully been used to assess RT in our laboratory 2,3,5-8 , as part of the ENCODE Consortium effort 52 , and in other laboratories 53, 54 . We have shown that Repli-seq gives similar results to those of Repli-chip, in both human and mouse cells 25 (Fig. 3) , and that comparisons of genome-wide RT can be made between Repli-seq and Repli-chip. The two platforms can even be combined for clustering experiments 20 . The advantages of Repli-seq are the genomic coverage (including repetitive sequences), which is dependent only upon the mappability and sequencing depth, the ability to distinguish SNPs or parse-phased genomes, and the ability to analyze any species with the same method.
sequence specificity
Replication timing profiles can be generated separately for individual homologs with allele-specific alignment when haplotype information is available. Here, we show an example using hybrid mouse ESCs (M. casteneus × M. musculus, Fig. 4 ) with an average heterozygosity of ~1%. Discrimination of the maternal and paternal genomes reveals subtle differences between homologous regions. The capacity to discriminate between two homologous chromosomes using our Repli-seq procedure could be used to assess RT of the two × chromosomes in female cells, which replicate at different times during S phase (the active × replicates during early S phase, whereas the inactive × replicates during late S phase) 32, 55, 56 . It is also useful to investigate the evolution of RT, and the influence of DNA sequence variation versus epigenetics (e.g., imprinting) on the regulation of RT 21, 22 . Finally, we anticipate Repli-seq being invaluable for comparing genetically manipulated homologs to unmanipulated control homologs to investigate cis-acting elements regulating RT, and the applications of bar-coded lineage tracing 57 and high-throughput reporter assays 24 to the study of RT.
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